RettigGreenlaw848
Strategy for the MOST lethal form of Cancer of the breast!
Ganoderma mushroom - Inflammatory breast cancers, also called IBC has been going to function as the most lethal, yet sadly least understood out of all the types of cancer of the breast cells.
What exactly is known is the lethality originates from its inherent lack of tumor mass rendering it incredibly difficult to detect and it is means of attacking the lymphatic system.
Inflammatory Breast Cancer differs from other advanced breast cancer varieties in how it forms what is known as tumor spheroids. These types of tumors have been located to become far more adhesive to cells.
There has been much research done lately on this type of cancer because of its extreme lethality.
Ganoderma mushroom - While surgery, drugs, radiation, chemotherapy as well as other such intrusive treatments have been popular there is a growing camp of forward thinking doctors which have seen amazing promise with the new shining star for oncologists.
Ganoderma (commercially sold as Karmic Balance ReishiCor) is really a medicinal mushroom that is the leading ingredient in Karmic Balance ReishiCor.
Reishi contains biological compounds that are cytotoxic against cancer cells. Yes, you read that right- TOXIC for the biggest form of Breast cancers cells!
medicinal mushrooms - Multiple results reveal that Reishi selectively inhibits cancer cell viability although it has no effect on the viability of noncancerous cells as shown in tests on mammals. Meaning it attacks the cell you need gone, and leaves the healthy ones alone!
Reishi gives Inflammatory Cancer of the breast a 1-2 punch by attempting to break the tumor spheroids bond as well. That one point alone gives Reishi incredible promise to use by those genetically predisposed to breast cancers.
Consider the battle to breast cancer-be proactive!
http://www.karmicbalancehealth.com/reishicor-with-immune-assisttm.html
Nutr Cancer. 2011 Oct;63(7):1085-94. Epub 2011 Sep 2. Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer. Martínez-Montemayor MM, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF. Source Department of Biochemistry, Universidad Central del Caribe, Med school, Bayamón, Puerto Rico. mmmtz92@gmail.com
